The blood cells in NSCLC and the changes after RFA

Lung cancer has attracted a lot of attention because of its high morbidity and mortality. The emergence of RFA provides a new treatment for unresectable NSCLC patients. In addition to killing in situ lung tumors, RFA also provides new immuno-activated antigens, for the treatment of lung cancer. It c...

Full description

Bibliographic Details
Main Authors: Yunfang Li, Dongdong Wang, Xiaoguang Li
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:International Journal of Hyperthermia
Subjects:
rfa
Online Access:http://dx.doi.org/10.1080/02656736.2020.1782486
id doaj-3a4ba20ca1ad4481b9ac4459e08ca0f0
record_format Article
spelling doaj-3a4ba20ca1ad4481b9ac4459e08ca0f02021-08-09T15:50:03ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572020-01-0137175376210.1080/02656736.2020.17824861782486The blood cells in NSCLC and the changes after RFAYunfang Li0Dongdong Wang1Xiaoguang Li2Department of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical SciencesMinimally Invasive Interventional Therapy Center Department, Qingdao Municipal HospitalDepartment of Minimally Invasive Tumor Therapies Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical SciencesLung cancer has attracted a lot of attention because of its high morbidity and mortality. The emergence of RFA provides a new treatment for unresectable NSCLC patients. In addition to killing in situ lung tumors, RFA also provides new immuno-activated antigens, for the treatment of lung cancer. It changes the tumor microenvironment and activates the entire immune system of patients. The peripheral blood cell count is easy to achieve and the blood cells are important in tumor immunity, which changes after RFA. On the one hand, the changes in blood cells identify the immune changes of NSCLC; on the other hand, it provides support and suspicion for the treatment of RFA.http://dx.doi.org/10.1080/02656736.2020.1782486nsclcrfablood cellimmunetumor microenvironment
collection DOAJ
language English
format Article
sources DOAJ
author Yunfang Li
Dongdong Wang
Xiaoguang Li
spellingShingle Yunfang Li
Dongdong Wang
Xiaoguang Li
The blood cells in NSCLC and the changes after RFA
International Journal of Hyperthermia
nsclc
rfa
blood cell
immune
tumor microenvironment
author_facet Yunfang Li
Dongdong Wang
Xiaoguang Li
author_sort Yunfang Li
title The blood cells in NSCLC and the changes after RFA
title_short The blood cells in NSCLC and the changes after RFA
title_full The blood cells in NSCLC and the changes after RFA
title_fullStr The blood cells in NSCLC and the changes after RFA
title_full_unstemmed The blood cells in NSCLC and the changes after RFA
title_sort blood cells in nsclc and the changes after rfa
publisher Taylor & Francis Group
series International Journal of Hyperthermia
issn 0265-6736
1464-5157
publishDate 2020-01-01
description Lung cancer has attracted a lot of attention because of its high morbidity and mortality. The emergence of RFA provides a new treatment for unresectable NSCLC patients. In addition to killing in situ lung tumors, RFA also provides new immuno-activated antigens, for the treatment of lung cancer. It changes the tumor microenvironment and activates the entire immune system of patients. The peripheral blood cell count is easy to achieve and the blood cells are important in tumor immunity, which changes after RFA. On the one hand, the changes in blood cells identify the immune changes of NSCLC; on the other hand, it provides support and suspicion for the treatment of RFA.
topic nsclc
rfa
blood cell
immune
tumor microenvironment
url http://dx.doi.org/10.1080/02656736.2020.1782486
work_keys_str_mv AT yunfangli thebloodcellsinnsclcandthechangesafterrfa
AT dongdongwang thebloodcellsinnsclcandthechangesafterrfa
AT xiaoguangli thebloodcellsinnsclcandthechangesafterrfa
AT yunfangli bloodcellsinnsclcandthechangesafterrfa
AT dongdongwang bloodcellsinnsclcandthechangesafterrfa
AT xiaoguangli bloodcellsinnsclcandthechangesafterrfa
_version_ 1721213742841069568